000132950 001__ 132950
000132950 005__ 20240229105041.0
000132950 0247_ $$2doi$$a10.1080/02813432.2018.1459429
000132950 0247_ $$2pmid$$apmid:29623749
000132950 0247_ $$2ISSN$$a0281-3432
000132950 0247_ $$2ISSN$$a0284-6020
000132950 0247_ $$2ISSN$$a1502-7724
000132950 0247_ $$2altmetric$$aaltmetric:41340847
000132950 037__ $$aDKFZ-2018-00589
000132950 041__ $$aeng
000132950 082__ $$a610
000132950 1001_ $$aWensing, Michel$$b0
000132950 245__ $$aEffects of a program to strengthen general practice care on hospitalisation rates: a comparative observational study.
000132950 260__ $$aAbingdon$$bTaylor & Francis Group$$c2018
000132950 3367_ $$2DRIVER$$aarticle
000132950 3367_ $$2DataCite$$aOutput Types/Journal article
000132950 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1527240778_23166
000132950 3367_ $$2BibTeX$$aARTICLE
000132950 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000132950 3367_ $$00$$2EndNote$$aJournal Article
000132950 520__ $$aTo determine the effect of a large-scale program to strengthen general practice on hospitalisation rates.This observational study compared enrolled patients in the program and a sample of non-participating patients from non-participating GPs in the same geographic area in Germany. Key components of the program are: prompt access to care, comprehensiveness, continuity, empanelment, data-driven quality improvement, computerized decision support, and additional reimbursement of general practices. The outcomes in this study were hospitalisation, rehospitalisation, and avoidable hospital admission up to four years after patient inclusion. Poisson regression models and generalized estimating equations were used to estimate intervention effects.In the baseline year, 19.1% were hospitalised and 13.6% had a potentially avoidable hospitalisation, 14.5% were rehospitalised within 4 weeks. Across the four observed years, yearly hospitalisations were 9.8 to 14.9% lower in enrolled patients, yearly re-hospitalisations were 5.3 to 11.5% lower, and yearly avoidable hospitalisations were 6.8 to 8.6% lower compared to the control cohort (all differences were statistically significant). The trend in the between-group difference for hospitalisations and re-hospitalisations increased, while it remained stable for avoidable hospitalisations.This study provides strong indications for the positive impact of strong general practice care on population outcomes. Key points A program to strengthen general practice in Germany comprised of prompt access to care, comprehensiveness, continuity, empanelment, data-driven quality improvement, computerized decision support, and additional reimbursement of general practices. Patients who remained in the program during 4 years had increasingly lowered rates of hospitalisation and rehospitalisation compared to a control group of patients. Avoidable hospitalisations were also lower, but no trend of further lowering was found. This might suggest a ceiling effect to impact of strong general practice on hospitalisations.
000132950 536__ $$0G:(DE-HGF)POF3-313$$a313 - Cancer risk factors and prevention (POF3-313)$$cPOF3-313$$fPOF III$$x0
000132950 588__ $$aDataset connected to CrossRef, PubMed,
000132950 7001_ $$aKolle, Petra Kaufmann$$b1
000132950 7001_ $$aSzecsenyi, Joachim$$b2
000132950 7001_ $$0P:(DE-He78)908880209a64ea539ae8dc5fdb7e0a91$$aStock, Christian$$b3$$udkfz
000132950 7001_ $$aLaux, Gunter$$b4
000132950 773__ $$0PERI:(DE-600)2027113-X$$a10.1080/02813432.2018.1459429$$gVol. 36, no. 2, p. 109 - 114$$n2$$p109 - 114$$tScandinavian journal of primary health care$$v36$$x1502-7724$$y2018
000132950 909CO $$ooai:inrepo02.dkfz.de:132950$$pVDB
000132950 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)908880209a64ea539ae8dc5fdb7e0a91$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000132950 9131_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000132950 9141_ $$y2018
000132950 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000132950 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bSCAND J PRIM HEALTH : 2015
000132950 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000132950 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000132950 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000132950 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000132950 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000132950 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000132950 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000132950 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000132950 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000132950 9201_ $$0I:(DE-He78)C070-20160331$$kC070$$lKlinische Epidemiologie und Alternsforschung$$x0
000132950 980__ $$ajournal
000132950 980__ $$aVDB
000132950 980__ $$aI:(DE-He78)C070-20160331
000132950 980__ $$aUNRESTRICTED